BACKGROUND: Determining infectious cross-transmission events in healthcare settings involves manual surveillance of case clusters by infection control personnel, followed by strain typing of clinical/environmental isolates suspected in said clusters. Recent advances in genomic sequencing and cloud computing now allow for the rapid molecular typing of infecting isolates. OBJECTIVE: To facilitate rapid recognition of transmission clusters, we aimed to assess infection control surveillance using whole-genome sequencing (WGS) of microbial pathogens to identify cross-transmission events for epidemiologic review. METHODS: Clinical isolates of Staphylococcus aureus, Enterococcus faecium, Pseudomonas aeruginosa, and Klebsiella pneumoniae were obtained prospectively at an academic medical center, from September 1, 2016, to September 30, 2017. Isolate genomes were sequenced, followed by single-nucleotide variant analysis; a cloud-computing platform was used for whole-genome sequence analysis and cluster identification. RESULTS: Most strains of the 4 studied pathogens were unrelated, and 34 potential transmission clusters were present. The characteristics of the potential clusters were complex and likely not identifiable by traditional surveillance alone. Notably, only 1 cluster had been suspected by routine manual surveillance. CONCLUSIONS: Our work supports the assertion that integration of genomic and clinical epidemiologic data can augment infection control surveillance for both the identification of cross-transmission events and the inclusion of missed and exclusion of misidentified outbreaks (ie, false alarms). The integration of clinical data is essential to prioritize suspect clusters for investigation, and for existing infections, a timely review of both the clinical and WGS results can hold promise to reduce HAIs. A richer understanding of cross-transmission events within healthcare settings will require the expansion of current surveillance approaches.
BACKGROUND: Determining infectious cross-transmission events in healthcare settings involves manual surveillance of case clusters by infection control personnel, followed by strain typing of clinical/environmental isolates suspected in said clusters. Recent advances in genomic sequencing and cloud computing now allow for the rapid molecular typing of infecting isolates. OBJECTIVE: To facilitate rapid recognition of transmission clusters, we aimed to assess infection control surveillance using whole-genome sequencing (WGS) of microbial pathogens to identify cross-transmission events for epidemiologic review. METHODS: Clinical isolates of Staphylococcus aureus, Enterococcus faecium, Pseudomonas aeruginosa, and Klebsiella pneumoniae were obtained prospectively at an academic medical center, from September 1, 2016, to September 30, 2017. Isolate genomes were sequenced, followed by single-nucleotide variant analysis; a cloud-computing platform was used for whole-genome sequence analysis and cluster identification. RESULTS: Most strains of the 4 studied pathogens were unrelated, and 34 potential transmission clusters were present. The characteristics of the potential clusters were complex and likely not identifiable by traditional surveillance alone. Notably, only 1 cluster had been suspected by routine manual surveillance. CONCLUSIONS: Our work supports the assertion that integration of genomic and clinical epidemiologic data can augment infection control surveillance for both the identification of cross-transmission events and the inclusion of missed and exclusion of misidentified outbreaks (ie, false alarms). The integration of clinical data is essential to prioritize suspect clusters for investigation, and for existing infections, a timely review of both the clinical and WGS results can hold promise to reduce HAIs. A richer understanding of cross-transmission events within healthcare settings will require the expansion of current surveillance approaches.
Authors: Alexander J Sundermann; Ahmed Babiker; Jane W Marsh; Kathleen A Shutt; Mustapha M Mustapha; Anthony W Pasculle; Chinelo Ezeonwuka; Melissa I Saul; Marissa P Pacey; Daria Van Tyne; Ashley M Ayres; Vaughn S Cooper; Graham M Snyder; Lee H Harrison Journal: Clin Infect Dis Date: 2020-05-23 Impact factor: 9.079
Authors: Alexander J Sundermann; Jieshi Chen; Praveen Kumar; Ashley M Ayres; Shu Ting Cho; Chinelo Ezeonwuka; Marissa P Griffith; James K Miller; Mustapha M Mustapha; A William Pasculle; Melissa I Saul; Kathleen A Shutt; Vatsala Srinivasa; Kady Waggle; Daniel J Snyder; Vaughn S Cooper; Daria Van Tyne; Graham M Snyder; Jane W Marsh; Artur Dubrawski; Mark S Roberts; Lee H Harrison Journal: Clin Infect Dis Date: 2022-08-31 Impact factor: 20.999
Authors: Jane Hawkey; Kalani Paranagama; Kate S Baker; Rebecca J Bengtsson; François-Xavier Weill; Nicholas R Thomson; Stephen Baker; Louise Cerdeira; Zamin Iqbal; Martin Hunt; Danielle J Ingle; Timothy J Dallman; Claire Jenkins; Deborah A Williamson; Kathryn E Holt Journal: Nat Commun Date: 2021-05-11 Impact factor: 14.919
Authors: Ming Da Qu; Humera Kausar; Stephen Smith; Peter G Lazar; Aimee R Kroll-Desrosiers; Carl Hollins; Bruce A Barton; Doyle V Ward; Richard T Ellison Journal: PLoS One Date: 2022-03-18 Impact factor: 3.240
Authors: Norelle L Sherry; Claire L Gorrie; Jason C Kwong; Charlie Higgs; Rhonda L Stuart; Caroline Marshall; Susan A Ballard; Michelle Sait; Tony M Korman; Monica A Slavin; Robyn S Lee; Maryza Graham; Marcel Leroi; Leon J Worth; Hiu Tat Chan; Torsten Seemann; M Lindsay Grayson; Benjamin P Howden Journal: Lancet Reg Health West Pac Date: 2022-04-12
Authors: Sarah E Sansom; Latania K Logan; Stefan J Green; Nicholas M Moore; Mary K Hayden Journal: Antimicrob Steward Healthc Epidemiol Date: 2021-06-24
Authors: Daniel R Evans; Marissa P Griffith; Alexander J Sundermann; Kathleen A Shutt; Melissa I Saul; Mustapha M Mustapha; Jane W Marsh; Vaughn S Cooper; Lee H Harrison; Daria Van Tyne Journal: Elife Date: 2020-04-14 Impact factor: 8.140